The mechanism of inhibition of antibody-based inhibitors of membrane-type serine protease 1 (MT-SP1).


Abstract

The mechanisms of inhibition of two novel scFv antibody inhibitors of the serine protease MT-SP1/matriptase reveal the basis of their potency and specificity. Kinetic experiments characterize the inhibitors as extremely potent inhibitors with K(I) values in the low picomolar range that compete with substrate binding in the S1 site. Alanine scanning of the loops surrounding the protease active site provides a rationale for inhibitor specificity. Each antibody binds to a number of residues flanking the active site, forming a unique three-dimensional binding epitope. Interestingly, one inhibitor binds in the active site cleft in a substrate-like manner, can be processed by MT-SP1 at low pH, and is a standard mechanism inhibitor of the protease. The mechanisms of inhibition provide a rationale for the effectiveness of these inhibitors, and suggest that the development of specific antibody-based inhibitors against individual members of closely related enzyme families is feasible, and an effective way to develop tools to tease apart complex biological processes.

Submission Details

ID: MzEPAtEQ3

Submitter: Shu-Ching Ou

Submission Date: Feb. 27, 2019, 3:18 p.m.

Version: 1

Publication Details
Farady CJ;Sun J;Darragh MR;Miller SM;Craik CS,J Mol Biol (2007) The mechanism of inhibition of antibody-based inhibitors of membrane-type serine protease 1 (MT-SP1). PMID:17475279
Additional Information

Structure view and single mutant data analysis

Study data

No weblogo for data of varying length.
Colors: D E R H K S T N Q A V I L M F Y W C G P
 

Data Distribution

Studies with similar sequences (approximate matches)

Correlation with other assays (exact sequence matches)


Relevant PDB Entries

Structure ID Release Date Resolution Structure Title
3NCL 2011-02-16 1.19 Crystal Structure of MT-SP1 bound to Benzamidine Phosphonate Inhibitor
3P8G 2011-08-03 1.2 Crystal Structure of MT-SP1 in complex with benzamidine
1EAX 2002-01-28 1.3 Crystal structure of MTSP1 (matriptase)
4IS5 2013-03-06 1.48 Crystal Structure of the ligand-free inactive Matriptase
3NPS 2011-07-06 1.5 Crystal structure of membrane-type serine protease 1 (MT-SP1) in complex with the Fab Inhibitor S4
4O9V 2014-05-28 1.9 Crystal structure of matriptase in complex with inhibitor
4R0I 2015-02-11 1.9 CRYSTAL STRUCTURE of MATRIPTASE in COMPLEX WITH INHIBITOR
4JZ1 2014-02-26 1.9 Crystal Structure of Matriptase in complex with Inhibitor
6N4T 2019-10-02 1.95 Crystal structure of Matriptase1 in complex with a peptidomimetic benzothiazole
3P8F 2011-08-10 2.0 Crystal Structure of MT-SP1 in complex with SFTI-1
4JYT 2014-03-19 2.0 Crystal Structure of Matriptase in complex with Inhibitor
4JZI 2014-02-26 2.0 Crystal Structure of Matriptase in complex with Inhibitor'.
4ISO 2013-03-06 2.01 Crystal Structure of Matriptase in complex with its inhibitor HAI-1
2GV6 2006-06-06 2.1 Crystal Structure of Matriptase with Inhibitor CJ-730
3SO3 2012-06-20 2.1 Structures of Fab-Protease Complexes Reveal a Highly Specific Non-Canonical Mechanism of Inhibition.
3BN9 2008-09-09 2.17 Crystal Structure of MT-SP1 in complex with Fab Inhibitor E2
4O97 2014-05-28 2.2 Crystal structure of matriptase in complex with inhibitor
2GV7 2006-06-06 2.2 Structure of Matriptase in Complex with Inhibitor CJ-672
4ISL 2013-03-06 2.29 Crystal Structure of the inactive Matriptase in complex with its inhibitor HAI-1
4ISN 2013-03-06 2.45 Crystal Structure of Matriptase in complex with its inhibitor HAI-1
5LYO 2017-10-25 2.5 Crystal structure of the zymogen matriptase catalytic domain
1EAW 2002-01-28 2.93 Crystal structure of the MTSP1 (matriptase)-BPTI (aprotinin) complex

Relevant UniProtKB Entries

Percent Identity Matching Chains Protein Accession Entry Name
99.6 Suppressor of tumorigenicity 14 protein Q9Y5Y6 ST14_HUMAN